Author:
Dralle Henning,Machens Andreas,Basa Johanna,Fatourechi Vahab,Franceschi Silvia,Hay Ian D.,Nikiforov Yuri E.,Pacini Furio,Pasieka Janice L.,Sherman Steven I.
Publisher
Springer Science and Business Media LLC
Reference261 articles.
1. World Health Organization. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs (eds DeLellis, R. A., Lloyd, R. V., Heitz, P. U. & Eng, C. ) 49–80 (IARC Press, 2004).
2. Nikiforov, Y. E. & Nikiforova, M. N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 7, 569–580 (2011).
3. Jung, C. K. et al. The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J. Clin. Endocrinol. Metab. 99, E276–E285 (2014). This study shows that the detection rate and the molecular profile of PTC have changed in the United States over the past three decades.
4. Albores-Saavedra, J., Henson, D. E., Glazer, E. & Schwartz, A. M. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype — papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr. Pathol. 18, 1–7 (2007).
5. Aschebrook-Kilfoy, B., Grogan, R. H., Ward, M. H., Kaplan, E. & Devesa, S. S. Follicular thyroid cancer incidence patterns in the United States, 1980–2009. Thyroid 23, 1015–1021 (2013).
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献